Why the study?
Does a cloned viral protein vaccine elicit neutralizing antibodies and protection against foot-and-mouth disease virus in cattle and swine?
Does a cloned viral protein vaccine elicit neutralizing antibodies and protection against foot-and-mouth disease virus in cattle and swine?
A cloned viral protein vaccine successfully elicited neutralizing antibodies and provided protection against foot-and-mouth disease in cattle and swine.
Hypothesis-generating for chimeric FMDV vaccines in livestock; leaves open field translation pending larger trials.
A DNA sequence coding for the immunogenic capsid protein VP3 of foot-and-mouth disease virus A12, prepared from the virion RNA, was ligated to a plasmid designed to express a chimeric protein from the Escherichia coli tryptophan promoter-operator system. When Escherichia coli transformed with this plasmid was grown in tryptophan-depleted media, approximately 17 percent of the total cellular protein was found to be an insoluble and stable chimeric protein. The purified chimeric protein competed equally on a molar basis with VP3 for specific antibodies to foot-and-mouth disease virus. When inoculated into six cattle and two swine, this protein elicited high levels of neutralizing antibody and protection against challenge with foot-and-mouth disease virus.
No takes yet. Share an insight, caveat, or question.
Kleid et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: